Seattle, WA, United States of America

Sindhu Cherian

This inventor holds 2 USPTO granted patents. Top assignee: University of Pennsylvania. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sindhu Cherian. Retrieved from https://idiyas.com/inventor/sindhu-cherian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sindhu Cherian: Innovator in Myelodysplastic Syndromes Diagnosis

Introduction

Sindhu Cherian is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of myelodysplastic syndromes (MDS). With a total of 2 patents, her work is paving the way for improved diagnostic methods in healthcare.

Latest Patents

Sindhu Cherian's latest patents focus on innovative methods for diagnosing myelodysplastic syndromes. The first patent relates to methods and kits for diagnosing and ascertaining the clinical course of MDS, as well as determining the response to therapy regimens. This invention provides essential tools for diagnosing and understanding clinical parameters associated with MDS based on unique surface markers. The second patent mirrors the first, emphasizing the importance of these methods and kits in clinical settings.

Career Highlights

Sindhu Cherian is affiliated with the University of Pennsylvania, where she continues her research and development in medical diagnostics. Her work has garnered attention for its potential to enhance patient care and treatment outcomes in individuals suffering from MDS.

Collaborations

Sindhu collaborates with notable colleagues, including Jonni Moore and Adam Bagg. These partnerships contribute to the advancement of her research and the implementation of her innovative diagnostic methods.

Conclusion

Sindhu Cherian's contributions to the diagnosis of myelodysplastic syndromes represent a significant advancement in medical technology. Her patents and ongoing research are vital for improving diagnostic accuracy and patient care in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…